Posted on 6/6/18
Better Buy: CVS Health Corp vs. Kroger Co
Mid-2015 was a high-water mark for brick-and-mortar retail shopping destinations like CVS Health (NYSE:CVS) and Kroger (NYSE:KR). Since then, however, shareholders don't have much to show . . .
Posted on 6/5/18
LakePharma and Harbour Antibodies Announce Partnership
LakePharma and Harbour Antibodies BV, a Harbour BioMed subsidiary, today announced a technology partnership providing LakePharma the right to utilize Harbour Antibodies' patented, H2L2 transgenic mouse . . .
Posted on 6/5/18
ImmunoGen Proposes Public Offering of Common Stock
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that it intends . . .
Posted on 6/5/18
Vericel Corp. Closes $74.8 Million Public Offering
CAMBRIDGE, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (Nasdaq:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, . . .
Posted on 6/5/18
Cytrellis Biosystems Completes $28.5 Million Series B Financing
Cytrellis Biosystems, Inc., a medical technology company developing a new, proprietary class of dermatologic aesthetic devices for the reduction of skin laxity, today announced that it . . .
Posted on 6/5/18
Nimbus Therapeutics Raises $65 Million
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nimbus Therapeutics, a privately held biotechnology company applying deep computational expertise throughout drug discovery and development, today announced that it has raised $65 million . . .
Posted on 6/5/18
T2 Biosystems Closes Public Offering
LEXINGTON, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced the closing of its underwritten public offering of 7,015,000 shares of common . . .
Posted on 6/5/18
bluebird bio (BLUE) ASCO Data Review Conference Call - Slideshow
The following slide deck was published by bluebird bio, Inc. in conjunction with this event. 120READ FULL ARTICLE HERE
Posted on 6/5/18
Thermo Fisher Scientific Opens U.S. Precision Medicine Science Center
BIO 2018 and ASMS 2018 -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today officially opened its U.S. Precision Medicine Science . . .
Posted on 6/5/18
Sesen Bio Announces Closing of Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio, Inc. (Nasdaq: SESN), a late-stage clinical company developing next-generation antibody-drug conjugate therapies for the treatment of cancer, today announced the closing of . . .
Posted on 6/5/18
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that, on June . . .
Posted on 6/5/18
Akebia Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), . . .
Posted on 6/5/18
Deciphera Pharmaceuticals Announces Proposed Public Offering of Common Stock
WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today announced that it has commenced a . . .
Posted on 6/4/18
Cogstate Announces European Approval for Healthcare Offering
BOSTON--(BUSINESS WIRE)--The cognitive science company, Cogstate, today announced that its Healthcare Division has received CE Mark approval for its CognigramTM digital cognitive assessment system.“Cogstate Healthcare is . . .
Posted on 6/4/18
Acquia Labs Expands Development of Conversational Interfaces
LONDON and BOSTON, June 04, 2018 (GLOBE NEWSWIRE) -- Digital experience company Acquia today announced it is rolling out voice-enabled search technologies to government agencies and . . .
Posted on 6/4/18
BIO Kicks off International Convention in Boston
BOSTON--(BUSINESS WIRE)--The 2018 BIO International Convention, the world’s premier life sciences event, today kicked off four days of inspiring keynote speeches, fireside chats and educational programming . . .
Posted on 6/4/18
Scholar Rock Announces Exercise in Full and Closing of Over-Allotment Option in Initial Public Offering
CAMBRIDGE, Mass., June 04, 2018 (GLOBE NEWSWIRE) -- Scholar Rock (NASDAQ:SRRK), a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment . . .
Posted on 6/3/18
Better Buy: Biogen Inc. vs. Celgene
Investors haven't been happy with either Biogen (NASDAQ:BIIB) or Celgene (NASDAQ:CELG)lately. But the level of discontent is much higher with Celgene. The biotech stock has dropped . . .
Posted on 6/3/18
Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
NEWTON, Mass., June 01, 2018 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that the Compensation Committee of Karyopharm’s Board of . . .
Posted on 6/3/18
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
BOSTON, June 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline . . .
Posted on 6/3/18
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BURLINGTON, Mass., June 01, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to eight new employees for an . . .
Posted on 6/1/18
Boston Scientific (BSX) Presents At Bernstein Thirty-Fourth Annual Strategic Decisions Conference - Slideshow
The following slide deck was published by Boston Scientific Corporation in conjunction with this event. 120READ FULL ARTICLE HERE
Posted on 6/1/18
Biostage Closes $3.6 Million Private Placement
Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, today announced that the Securities . . .
Posted on 6/1/18
Why These Biotech Startups Are Facing A 550% Rent Hike
The way CEO Briana Wronko sees it, the University City Science Center and Boston-based Cambridge
Posted on 6/1/18
Vericel Prices $65 Million Public Offering of Common Stock
CAMBRIDGE, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, . . .

